CN101891665A - (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method - Google Patents
(3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method Download PDFInfo
- Publication number
- CN101891665A CN101891665A CN2009100518202A CN200910051820A CN101891665A CN 101891665 A CN101891665 A CN 101891665A CN 2009100518202 A CN2009100518202 A CN 2009100518202A CN 200910051820 A CN200910051820 A CN 200910051820A CN 101891665 A CN101891665 A CN 101891665A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- acid
- chloride
- acetyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BIXVDLFCXJRNAJ-UYFOZJQFSA-N (3S,4S)-4-acetyl-3-[(1R)-1-hydroxyethyl]azetidin-2-one Chemical compound C(C)(=O)[C@@H]1[C@H](C(N1)=O)[C@@H](C)O BIXVDLFCXJRNAJ-UYFOZJQFSA-N 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims description 70
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 239000002585 base Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- -1 benzhydryl protecting group Chemical group 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 10
- 229910002027 silica gel Inorganic materials 0.000 claims description 10
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 230000002140 halogenating effect Effects 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 4
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 150000008282 halocarbons Chemical class 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- ONQBOTKLCMXPOF-UHFFFAOYSA-N 1-ethylpyrrolidine Chemical compound CCN1CCCC1 ONQBOTKLCMXPOF-UHFFFAOYSA-N 0.000 claims description 2
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 claims description 2
- OZGSEIVTQLXWRO-UHFFFAOYSA-N 2,4,6-trichlorobenzoyl chloride Chemical compound ClC(=O)C1=C(Cl)C=C(Cl)C=C1Cl OZGSEIVTQLXWRO-UHFFFAOYSA-N 0.000 claims description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 2
- 239000012346 acetyl chloride Substances 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 150000008365 aromatic ketones Chemical class 0.000 claims description 2
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- GWHDKFODLYVMQG-UBHAPETDSA-N [(2r,3r)-3-[(1r)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl] acetate Chemical compound CC(C)(C)[Si](C)(C)O[C@H](C)[C@@H]1[C@@H](OC(C)=O)NC1=O GWHDKFODLYVMQG-UBHAPETDSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- PEXQFZFDDLTDET-FSPWUOQZSA-N (3s,4s)-4-acetyl-1-benzhydryl-3-[(1r)-1-hydroxyethyl]azetidin-2-one Chemical compound O=C1[C@H]([C@H](O)C)[C@@H](C(C)=O)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 PEXQFZFDDLTDET-FSPWUOQZSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 125000003460 beta-lactamyl group Chemical group 0.000 description 3
- FOSFXTWUGMIGJG-UHFFFAOYSA-N butanoyloxy butaneperoxoate Chemical compound CCCC(=O)OOOC(=O)CCC FOSFXTWUGMIGJG-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- SEDGGCMDYFKAQN-UHFFFAOYSA-N 3-methyloxirane-2-carboxylic acid Chemical compound CC1OC1C(O)=O SEDGGCMDYFKAQN-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- AGUHJOKVHVZINS-SWLXLVAMSA-M sodium;(2r,3r)-3-methyloxirane-2-carboxylate Chemical compound [Na+].C[C@H]1O[C@H]1C([O-])=O AGUHJOKVHVZINS-SWLXLVAMSA-M 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HVCFCNAITDHQFX-UHFFFAOYSA-N 1-cyclopropylethanone Chemical compound CC(=O)C1CC1 HVCFCNAITDHQFX-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- RAUONEIRZDXULB-HGWBJXFBSA-N [(2r,3s)-3-[(1r)-1-hydroxyethyl]-4-oxoazetidin-2-yl] acetate Chemical compound C[C@@H](O)[C@H]1[C@@H](OC(C)=O)NC1=O RAUONEIRZDXULB-HGWBJXFBSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- VQNPSCRXHSIJTH-UHFFFAOYSA-N cadmium(2+);carbanide Chemical compound [CH3-].[CH3-].[Cd+2] VQNPSCRXHSIJTH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮及其制备方法。本发明还提供了其中间体(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(I)和(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(II)及其制备方法。本发明的方法原料价廉易得,收率高,操作简便,对环境友好,易实现规模化生产。 The invention provides (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and a preparation method thereof. The present invention also provides its intermediate (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide (I) and (3S, 4S)-1-benzidine Base-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (II) and its preparation method. The method of the invention has the advantages of cheap and easy-to-obtain raw materials, high yield, simple operation, environmental friendliness and easy realization of large-scale production.
Description
技术领域technical field
本发明涉及药物化学领域,具体涉及化合物(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮及其制备方法,本发明还涉及其中间体(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺和(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮及其制备方法。The invention relates to the field of medicinal chemistry, in particular to the compound (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and a preparation method thereof. Involving its intermediates (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutanamide and (3S, 4S)-1-benzhydryl-3-((R )-1-hydroxyethyl)-4-acetyl-2-azetidinone and its preparation method.
背景技术Background technique
青霉烯和碳青霉烯类抗生素是上世纪70年代发展起来的非典型β-内酰胺类抗生素。其抗菌作用强,对β-内酰胺酶稳定。在目前的临床抗感染治疗,尤其是对耐药菌引起的感染治疗中,占有重要的地位。Penem and carbapenem antibiotics are atypical β-lactam antibiotics developed in the 1970s. It has strong antibacterial effect and is stable to β-lactamase. It occupies an important position in the current clinical anti-infection treatment, especially in the treatment of infections caused by drug-resistant bacteria.
(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(简称4-AA)是制备青霉烯和碳青霉烯类抗生素的关键中间体,其结构式如式(VI)所示:(3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone (4-AA for short) is the preparation of Penicillium The key intermediate of alkene and carbapenem antibiotics, its structural formula is as shown in formula (VI):
4-AA的合成报道很多,J Chem Soc Chem Com,1992,662-664;J OrgChem,1992,57:4232-4237;Chem Pharm Bull 1992,40:1094-1097;Tetrahedron Lett,1982,23:2293-2296;Tetrahedron Lett,1986,27:4961-4964;Tetrahedron Lett,1988,29:1409-1412;Tetrahedron Lett,1998,39:7779-7782;WO9807691;EP0774463;EP167154;JP5239019;JP4173776;JP4173795;JP2134349都报道了4-AA的制备方法。There are many reports on the synthesis of 4-AA, J Chem Soc Chem Com, 1992, 662-664; J OrgChem, 1992, 57: 4232-4237; Chem Pharm Bull 1992, 40: 1094-1097; Tetrahedron Lett, 1982, 23: 2293 -2296;Tetrahedron Lett,1986,27:4961-4964;Tetrahedron Lett,1988,29:1409-1412;Tetrahedron Lett,1998,39:7779-7782;WO9807691;EP0774463;EP167154;JP5239019;JP4173776;JP4173795;JP2134349都The preparation method of 4-AA was reported.
4-AA分子中含有3个手性中心,合成难度大。如何引入3个手性中心,立体选择性的形成β-内酰胺环是合成的关键所在。The 4-AA molecule contains three chiral centers, which is difficult to synthesize. How to introduce three chiral centers and stereoselectively form the β-lactam ring is the key to the synthesis.
采用天然手性源L-苏氨酸为起始原料引入2个手性中心,再在后续反应中构建第三个手性中心,这种方法已报道的有以下几种:The natural chiral source L-threonine is used as the starting material to introduce two chiral centers, and then the third chiral center is constructed in the subsequent reaction. This method has been reported as follows:
J Am Chem Soc,1985,1438-1439J Am Chem Soc, 1985, 1438-1439
该路线需经过不稳定的2,3-环氧丁酸中间体,并且形成β-内酰胺环的立体选择性不高,脱保护要使用对环境有害的硝酸铈铵,得到的苯甲酰氧化合物还需要与醋酸钾反应才能得到4-AA。This route needs to pass through the unstable 2,3-epoxybutyric acid intermediate, and the stereoselectivity of forming the β-lactam ring is not high, and the deprotection needs to use cerium ammonium nitrate which is harmful to the environment, and the obtained benzoyloxy The compound also needs to be reacted with potassium acetate to give 4-AA.
(2)Tetrahedron,1984,1795-1802(2) Tetrahedron, 1984, 1795-1802
该路线避免了经过不稳定的2,3-环氧丁酸中间体,但是缩合形成酰胺化合物用到价格较贵的DCC,形成β-内酰胺环的收率较低。路线中还用到了剧毒物质二甲基镉。This route avoids the unstable 2,3-epoxybutyric acid intermediate, but the condensation to form the amide compound uses more expensive DCC, and the yield of the β-lactam ring is low. The highly toxic substance dimethyl cadmium is also used in the route.
(3)Eur J Org Chem,2006,3755-3766(3) Eur J Org Chem, 2006, 3755-3766
与方法(1)和(2)相比,方法(3)原料易得,操作简便,但是存在以下问题:1.起始原料需用到甲基环丙基酮,市场不易得。2.由于脱保护产物水溶性大,与对甲苯磺酸一起溶于水中,不易分离。3.得到的环丙甲酰基化合物必须与醋酸盐再经过一步转化才能得到4-AA。Compared with methods (1) and (2), method (3) has easy-to-obtain raw materials and is easy to operate, but has the following problems: 1. The starting material needs to use methyl cyclopropyl ketone, which is not easily available in the market. 2. Due to the high water solubility of the deprotected product, it is soluble in water together with p-toluenesulfonic acid and is not easy to separate. 3. The obtained cyclopropylformyl compound must be transformed with acetate to obtain 4-AA.
发明内容Contents of the invention
为了改进(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮的合成工艺,在兼顾成本和安全操作的情况下提高反应收率,提出了本发明。In order to improve the synthetic technique of (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone, taking into account cost and In order to improve the reaction yield under the condition of safe operation, the present invention is proposed.
根据本发明的第一个方面,其提供了一种具有如下结构式的式(III)化合物[(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮]:According to the first aspect of the present invention, it provides a compound of formula (III) [(3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2 having the following structural formula -azetidinone]:
式(III)化合物可以用作合成(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(4-AA)的中间体。合成路线如下:Formula (III) compound can be used as synthetic (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxyl group-2-azetidinone ( 4-AA) intermediates. The synthetic route is as follows:
根据本发明的技术方案,上述(III)化合物是以下列两种化合物作为关键中间体制备得到的:According to the technical scheme of the present invention, the above-mentioned (III) compound is prepared by using the following two compounds as key intermediates:
具有如下结构式(I)的化合物[(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺]:A compound [(2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide] with the following structural formula (I):
以及,as well as,
具有如下结构式的式(II)化合物[(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮]:A compound of formula (II) having the following structural formula [(3S,4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone] :
上述式(I)化合物和式(II)化合物是制备式(III)化合物的关键中间体。The above-mentioned compound of formula (I) and compound of formula (II) are key intermediates for preparing the compound of formula (III).
根据本发明的第二个方面,其还提供了一种制备上述的式(III)化合物的方法,其包括以下步骤:According to a second aspect of the present invention, it also provides a method for preparing the above-mentioned compound of formula (III), which comprises the following steps:
a)将具有如下结构式的式(IV)化合物(2R,3R)-2,3-环氧丁酸钠在酰氯活化下,加入碱在有机溶剂中和式(V)化合物1-二苯甲基胺基-2-丙酮进行缩合,得到式(I)化合物;a) The formula (IV) compound (2R, 3R)-2,3-epoxybutyric acid sodium with the following structural formula is activated by acid chloride, and a base is added in an organic solvent to neutralize the formula (V) compound 1-benzhydryl Amino-2-propanone is condensed to obtain a compound of formula (I);
b)使式(I)化合物在碱的催化下在有机溶剂中闭环,得到式(II)化合物;b) ring-closing the compound of formula (I) in an organic solvent under the catalysis of a base to obtain the compound of formula (II);
(I) (II)(I) (II)
c)使式(II)化合物在卤化剂和硅胶或者质子酸作用下在有机溶剂中脱除二苯甲基保护基,得到式(III)化合物。c) removing the benzhydryl protecting group from the compound of formula (II) in an organic solvent under the action of a halogenating agent and silica gel or protonic acid to obtain the compound of formula (III).
其中步骤a)本发明将活化试剂缓慢滴加入环氧丁酸钠(IV)与合适溶剂组成的悬浊液中,转化为环氧丁酰氯后再加入碱和化合物(V)反应生成式(I)化合物。合适的活化试剂酰氯选自一种或多种下列物质:乙酰氯、二氯亚砜、草酰氯、特戊酰氯、氯甲酸异丁酯、2,4,6-三氯苯甲酰氯。合适的碱选自一种或多种下列物质:二甲胺、二乙胺、二异丙胺、N-甲基苯胺、哌啶、吡咯、吡啶、吗啉、二异丙基乙胺、三乙胺、N,N-二甲基苯胺、N-乙基哌啶、N-甲基吗啉、N-乙基吡咯烷、N,N,N’N’-四甲基乙二胺。合适的溶剂选自一种或多种下列物质:卤代烃类、烷烃、酯类、乙醚、异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。其中,化合物(V)的用量是化合物(IV)的1~2倍,活化试剂的用量是化合物(IV)的1~2倍,加入的碱作为缚酸剂与反应中产生的氯化氢反应,促使反应转化。碱的用量是化合物(IV)的1~5倍。反应温度为-50℃~40℃,优选为-20~25℃。Wherein in step a) the present invention slowly adds the activating reagent dropwise into the suspension composed of sodium epoxybutyrate (IV) and a suitable solvent, converts it into epoxybutyryl chloride and then adds alkali and compound (V) to react to generate formula (I ) compound. Suitable activating reagents are acid chlorides selected from one or more of the following: acetyl chloride, thionyl chloride, oxalyl chloride, pivaloyl chloride, isobutyl chloroformate, 2,4,6-trichlorobenzoyl chloride. Suitable bases are selected from one or more of the following: dimethylamine, diethylamine, diisopropylamine, N-methylaniline, piperidine, pyrrole, pyridine, morpholine, diisopropylethylamine, triethylamine Amine, N,N-dimethylaniline, N-ethylpiperidine, N-methylmorpholine, N-ethylpyrrolidine, N,N,N'N'-tetramethylethylenediamine. Suitable solvents are selected from one or more of the following: halogenated hydrocarbons, alkanes, esters, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, acetonitrile. Wherein, the amount of compound (V) is 1 to 2 times that of compound (IV), and the amount of activating reagent is 1 to 2 times that of compound (IV), and the added base acts as an acid-binding agent to react with the hydrogen chloride produced in the reaction to promote reaction conversion. The amount of base used is 1 to 5 times that of compound (IV). The reaction temperature is -50°C to 40°C, preferably -20 to 25°C.
其中步骤b)本发明将式(I)化合物在碱的催化下在有机溶剂中闭环,得到式化合物(II),合适的碱选自一种或多种下列物质:六甲基二硅胺锂,六甲基二硅胺钠,二异丙胺锂。合适的溶剂选自一种或多种下列物质:卤代烃、烷烃、酯类、四氢呋喃、乙醚、异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。其中,化合物(I)在碱的作用下生成烯醇式进而进攻环氧上的碳,闭环生成化合物(II)。碱的用量是式(I)化合物的1~2倍。反应温度-20℃~40℃,优选为-20~25℃。Wherein step b) in the present invention, the compound of formula (I) is ring-closed in an organic solvent under the catalysis of a base to obtain the compound of formula (II), and the suitable base is selected from one or more of the following substances: lithium hexamethyldisilazide , Sodium Hexamethyldisilazide, Lithium Diisopropylamide. Suitable solvents are selected from one or more of the following: halogenated hydrocarbons, alkanes, esters, tetrahydrofuran, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, acetonitrile. Among them, the compound (I) generates an enol formula under the action of a base and then attacks the carbon on the epoxy, and the ring is closed to generate the compound (II). The amount of base used is 1 to 2 times that of the compound of formula (I). The reaction temperature is -20°C to 40°C, preferably -20°C to 25°C.
其中步骤c)本发明将式(II)化合物溶于合适的有机溶剂中,在卤化剂的作用下生成卤化物,再与水反应转化为羟基化合物,在硅胶或者质子酸的作用下脱除保护基得到式(III)化合物。合适卤化剂选自一种或多种下列物质:N-氯代丁二酰亚胺、N-溴代丁二酰亚胺。优选为N-溴代丁二酰亚胺。合适的溶剂选自一种或多种下列物质:脂肪酮、芳香酮、烷烃、卤代烷、乙腈、四氢呋喃、乙醚,异丙醚、甲基叔丁基醚、苯、甲苯、二甲苯等。质子酸为无机酸、有机酸,例如,其可以选自一种或多种下列酸:盐酸,硫酸,硝酸,磷酸,对甲苯磺酸,乙酸,甲酸等。卤化剂的用量是式(II)化合物的1~2倍,硅胶或者质子酸的用量是式(II)化合物的1~5倍。反应温度为0℃~100℃,优选为20~80℃。Wherein step c) the present invention dissolves the compound of formula (II) in a suitable organic solvent, generates a halide under the action of a halogenating agent, then reacts with water and converts it into a hydroxyl compound, and deprotects it under the action of silica gel or protonic acid group to obtain the compound of formula (III). Suitable halogenating agents are selected from one or more of the following: N-chlorosuccinimide, N-bromosuccinimide. N-bromosuccinimide is preferred. Suitable solvents are selected from one or more of the following: aliphatic ketones, aromatic ketones, alkanes, haloalkanes, acetonitrile, tetrahydrofuran, diethyl ether, isopropyl ether, methyl tert-butyl ether, benzene, toluene, xylene, and the like. Protic acid is inorganic acid, organic acid, for example, it can be selected from one or more of the following acids: hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, p-toluenesulfonic acid, acetic acid, formic acid and the like. The amount of the halogenating agent is 1-2 times that of the compound of formula (II), and the amount of silica gel or protonic acid is 1-5 times that of the compound of formula (II). The reaction temperature is 0°C to 100°C, preferably 20 to 80°C.
综上所述,本发明的起始原料可用价廉易得的L-苏氨酸和氯丙酮合成得到,脱除二苯甲基保护基时不使用PTSA等酸而采用硅胶,反应温和,后处理简单,产物易纯化。并且最后不需与醋酸盐反应而直接得到4-AA,路线简练。In summary, the starting materials of the present invention can be synthesized from cheap and easy-to-obtain L-threonine and chloroacetone. When removing the benzhydryl protecting group, instead of using acids such as PTSA, silica gel is used, and the reaction is mild. The treatment is simple and the product is easy to purify. And in the end, 4-AA can be directly obtained without reacting with acetate, and the route is concise.
具体实施方式Detailed ways
下面结合实施例对本发明作进一步阐述,但这些实施例不对本发明构成任何限制。The present invention will be further described below in conjunction with examples, but these examples do not constitute any limitation to the present invention.
实施例1:(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(式(I)化合物)的制备Embodiment 1: the preparation of (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutanamide (formula (I) compound)
在一装有磁力搅拌机、温度计的250mL四口圆底烧瓶中,加入(2R,3R)-2,3-环氧丁酸钠7.9g,四氢呋喃100mL。冷却至-15℃后,滴加草酰氯3.7mL,在该温度下搅拌2小时,加入无水吡啶5.3mL,1-二苯甲基胺基-2-丙酮6.4g,搅拌1小时后升至室温继续搅拌2小时,加入100mL乙酸乙酯,5%碳酸氢钠溶液洗涤,分液后有机相用盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(I)7.2g,收率85.6%。In a 250 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 7.9 g of sodium (2R,3R)-2,3-epoxybutyrate and 100 mL of tetrahydrofuran. After cooling to -15°C, add 3.7 mL of oxalyl chloride dropwise, stir at this temperature for 2 hours, add 5.3 mL of anhydrous pyridine, 6.4 g of 1-benzhydrylamino-2-propanone, stir for 1 hour and then rise to Stirring was continued at room temperature for 2 hours, 100 mL of ethyl acetate was added, washed with 5% sodium bicarbonate solution, the organic phase was washed with brine after liquid separation, dried over anhydrous magnesium sulfate, filtered, and the solvent was evaporated, and the compound (I) was obtained by silica gel column chromatography 7.2 g, yield 85.6%.
MS:324.2(M+H);MS: 324.2 (M+H);
1HNMR:(400MHz,CDCl3)1.18(3H,m),2.13(3H,s),2.93(1H,m),3.47(1H,m),4.38(1H,s),6.16(1H,s),7.10-7.33(10H,m)。 1 HNMR: (400MHz, CDCl 3 ) 1.18(3H, m), 2.13(3H, s), 2.93(1H, m), 3.47(1H, m), 4.38(1H, s), 6.16(1H, s) , 7.10-7.33 (10H, m).
实施例2:(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(式(I)化合物)的制备Embodiment 2: the preparation of (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide (formula (I) compound)
在一装有磁力搅拌机、温度计的250mL四口圆底烧瓶中,加入(2R,3R)-2,3-环氧丁酸钠7.9g,二氯甲烷100mL。冷却至-20℃后,滴加二氯亚砜4.9g,在该温度下搅拌2小时,加入三乙胺10.5g,1-二苯甲基胺基-2-丙酮6.4g,搅拌1小时后升温至回流反应2小时,加入100mL乙酸乙酯,5%碳酸氢钠溶液洗涤,分液后有机相用盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(I)7.2g,收率82.0%。In a 250 mL four-necked round bottom flask equipped with a magnetic stirrer and a thermometer, 7.9 g of sodium (2R,3R)-2,3-epoxybutyrate and 100 mL of dichloromethane were added. After cooling to -20°C, add 4.9 g of thionyl chloride dropwise, stir at this temperature for 2 hours, add 10.5 g of triethylamine, 6.4 g of 1-benzhydrylamino-2-propanone, and stir for 1 hour Heat up to reflux reaction for 2 hours, add 100mL ethyl acetate, wash with 5% sodium bicarbonate solution, wash the organic phase with brine after liquid separation, dry over anhydrous magnesium sulfate, evaporate the solvent after filtration, and obtain compound (I )7.2g, yield 82.0%.
MS:324.2(M+H);MS: 324.2 (M+H);
1HNMR:(400MHz,CDCl3)1.18(3H,m),2.13(3H,s),2.93(1H,m),3.47(1H,m),4.38(1H,s),6.16(1H,s),7.10-7.33(10H,m)。 1 HNMR: (400MHz, CDCl 3 ) 1.18(3H, m), 2.13(3H, s), 2.93(1H, m), 3.47(1H, m), 4.38(1H, s), 6.16(1H, s) , 7.10-7.33 (10H, m).
实施例3:(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(式(II)化合物)的制备Example 3: (3S, 4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (compound of formula (II)) preparation of
在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(I)化合物7.0g,二氯甲烷250mL。冷却至-20℃后,滴加LDA(1mol/L)26.4mL,滴加完毕升温至回流反应3小时,加入1N HCl 30mL,乙酸乙酯150mL,分液后有机相用5%碳酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(II)5.4g,收率77.4%。In a 500 mL four-necked round bottom flask equipped with a magnetic stirrer and a thermometer, 7.0 g of the compound of formula (I) and 250 mL of dichloromethane were added. After cooling to -20°C, add LDA (1mol/L) 26.4mL dropwise, heat up to reflux for 3 hours after the dropwise addition, add 1N HCl 30mL, ethyl acetate 150mL, and use 5% sodium bicarbonate solution for the organic phase after liquid separation Washing, washing with brine, drying over anhydrous magnesium sulfate, filtering and distilling off the solvent, silica gel column chromatography to obtain compound (II) 5.4g, yield 77.4%.
MS:324.2(M+H),346(M+Na)MS: 324.2(M+H), 346(M+Na)
1HNMR:(400MHz,CDCl3)1.28(3H,m),1.80(3H,s),2.96(1H,m),4.24(1H,m),4.56(1H,s),5.90(1H,s),7.25-7.33(10H,m) 1 HNMR: (400MHz, CDCl 3 ) 1.28(3H, m), 1.80(3H, s), 2.96(1H, m), 4.24(1H, m), 4.56(1H, s), 5.90(1H, s) , 7.25-7.33 (10H, m)
实施例4:(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(式(II)化合物)的制备Example 4: (3S, 4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (compound of formula (II)) preparation of
在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(I)化合物7.0g,四氢呋喃250mL。冷却至-15℃后,滴加LiHMDS(1mol/L)26.4mL,滴加完毕升至室温反应3小时,加入1N HCl30mL,乙酸乙酯150mL,分液后有机相用5%碳酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(II)5.6g,收率80.3%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 7.0 g of the compound of formula (I) and 250 mL of tetrahydrofuran. After cooling to -15°C, add LiHMDS (1mol/L) 26.4mL dropwise, rise to room temperature and react for 3 hours after the dropwise addition, add 1N HCl30mL, ethyl acetate 150mL, and wash the organic phase with 5% sodium bicarbonate solution after liquid separation , washed with brine, dried over anhydrous magnesium sulfate, filtered, and evaporated to remove the solvent. Silica gel column chromatography gave 5.6 g of compound (II), with a yield of 80.3%.
MS:324.2(M+H),346(M+Na)MS: 324.2(M+H), 346(M+Na)
1HNMR:(400MHz,CDCl3)1.28(3H,m),1.80(3H,s),2.96(1H,m),4.24(1H,m),4.56(1H,s),5.90(1H,s),7.25-7.33(10H,m) 1 HNMR: (400MHz, CDCl 3 ) 1.28(3H, m), 1.80(3H, s), 2.96(1H, m), 4.24(1H, m), 4.56(1H, s), 5.90(1H, s) , 7.25-7.33 (10H, m)
实施例5:(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮(式(III)化合物)的制备Example 5: Preparation of (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone (compound of formula (III))
在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(II)化合物5.0g,氯代丁二酰亚胺4.1g,二氯甲烷150mL,水100mL。室温下光照搅拌反应过夜,有机相用5%亚硫酸氢钠洗涤后加入对甲苯磺酸10.0g,室温反应12小时,反应结束后蒸除溶剂,加入冷水200mL,过滤得到的滤液减压浓缩得到的粗品经硅胶柱层析得到化合物(III)1.9g,收率78.2%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 5.0 g of the compound of formula (II), 4.1 g of chlorosuccinimide, 150 mL of dichloromethane, and 100 mL of water. Stir the reaction at room temperature overnight, wash the organic phase with 5% sodium bisulfite, add 10.0 g of p-toluenesulfonic acid, react at room temperature for 12 hours, evaporate the solvent after the reaction, add 200 mL of cold water, and concentrate the obtained filtrate under reduced pressure to obtain The crude product was subjected to silica gel column chromatography to obtain 1.9 g of compound (III), with a yield of 78.2%.
MS:158(M+H)MS: 158(M+H)
1H-NMR:(400MHz,CDCl3)1.23(3H,s),1.77(3H,m),3.18(1H,m),3.65(1H,m),4.22(1H,s),4.30(1H,m),4.81(1H,s)。 1 H-NMR: (400MHz, CDCl 3 ) 1.23(3H, s), 1.77(3H, m), 3.18(1H, m), 3.65(1H, m), 4.22(1H, s), 4.30(1H, m), 4.81 (1H, s).
实施例6:(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮(式(III)化合物)的制备Example 6: Preparation of (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone (compound of formula (III))
在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(II)化合物5.0g,溴代丁二酰亚胺3.0g,二氯甲烷150mL,水100mL。室温下光照搅拌反应过夜,有机相用5%亚硫酸氢钠洗涤后蒸除二氯甲烷,加入100mL四氢呋喃,加入硅胶10.0g,回流反应12小时,反应结束后过滤除去硅胶,用少量甲醇洗涤硅胶,合并滤液后蒸除四氢呋喃,加入水200mL,甲苯洗涤(3×100mL),分液,水相减压浓缩得到化合物(III)2.1g,收率86.4%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 5.0 g of the compound of formula (II), 3.0 g of bromosuccinimide, 150 mL of dichloromethane, and 100 mL of water. Stir the reaction under light at room temperature overnight, wash the organic phase with 5% sodium bisulfite, evaporate dichloromethane, add 100mL tetrahydrofuran, add 10.0g silica gel, reflux reaction for 12 hours, filter to remove silica gel after the reaction, wash the silica gel with a small amount of methanol After combining the filtrates, the tetrahydrofuran was distilled off, 200 mL of water was added, washed with toluene (3×100 mL), separated, and the aqueous phase was concentrated under reduced pressure to obtain 2.1 g of compound (III), with a yield of 86.4%.
MS:158(M+H)MS: 158(M+H)
1H-NMR:(400MHz,CDCl3)1.23(3H,s),1.77(3H,m),3.18(1H,m),3.65(1H,m),4.22(1H,s),4.30(1H,m),4.81(1H,s)。 1 H-NMR: (400MHz, CDCl 3 ) 1.23(3H, s), 1.77(3H, m), 3.18(1H, m), 3.65(1H, m), 4.22(1H, s), 4.30(1H, m), 4.81 (1H, s).
实施例7:(3S,4R)-3-((R)-1-羟基乙基)-4-乙酰氧基-2-氮杂环丁酮(式(VII)化合物)的制备Example 7: Preparation of (3S, 4R)-3-((R)-1-hydroxyethyl)-4-acetoxy-2-azetidinone (compound of formula (VII))
在一装有磁力搅拌机、温度计的500mL四口烧瓶中,加入式(III)化合物4.4g,间氯过氧苯甲酸12.0g,二氯甲烷200mL。室温搅拌过夜,反应结束后加入5%亚硫酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤蒸除溶剂硅胶柱层析得到化合物(VII)4.2g,收率87.5%。In a 500 mL four-necked flask equipped with a magnetic stirrer and a thermometer, add 4.4 g of the compound of formula (III), 12.0 g of m-chloroperoxybenzoic acid, and 200 mL of dichloromethane. Stir at room temperature overnight, add 5% sodium bisulfite solution to wash after the reaction, wash with brine, dry over anhydrous magnesium sulfate, filter and distill off the solvent by silica gel column chromatography to obtain 4.2 g of compound (VII), with a yield of 87.5%.
MS:196(M+Na),214(M+Na+H2O),228(M+Na+CH3OH)MS: 196(M+Na), 214(M+Na+ H2O ), 228(M+Na+ CH3OH )
实施例8:(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(4-AA)的制备Example 8: (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone (4-AA) preparation
在一装有磁力搅拌机、温度计的500mL四口烧瓶中,加入式(VII)化合物4.2g,叔丁基二甲基氯硅烷15.8g,咪唑21.6g,DMF200mL。室温搅拌过夜,反应结束后加入乙酸乙酯200mL,盐水洗涤,无水硫酸镁干燥,过滤蒸除溶剂硅胶柱层析得到化合物(VII)6.4g,收率91.8%,mp 106~108℃,(c=1.0,CHCl3)。In a 500 mL four-neck flask equipped with a magnetic stirrer and a thermometer, add 4.2 g of the compound of formula (VII), 15.8 g of tert-butyldimethylchlorosilane, 21.6 g of imidazole, and 200 mL of DMF. Stir overnight at room temperature. After the reaction, 200 mL of ethyl acetate was added, washed with brine, dried over anhydrous magnesium sulfate, filtered and evaporated to remove the solvent by silica gel column chromatography to obtain 6.4 g of compound (VII), yield 91.8%, mp 106-108 °C, (c=1.0, CHCl3 ).
ESI-MS(m/z):310(M+H+Na),342(M+H+Na+CH3OH)ESI-MS(m/z): 310(M+H+Na), 342(M+H+Na+ CH3OH )
1H-NMR(CDCl3)δ:0.07(6H,s),0.87(9H,s),1.26(3H,m),2.10(3H,s),3.18(1H,m),4.22(1H,m),5.84(1H,m),6.47(1H,s) 1 H-NMR (CDCl 3 ) δ: 0.07 (6H, s), 0.87 (9H, s), 1.26 (3H, m), 2.10 (3H, s), 3.18 (1H, m), 4.22 (1H, m ), 5.84(1H, m), 6.47(1H, s)
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910051820 CN101891665B (en) | 2009-05-22 | 2009-05-22 | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910051820 CN101891665B (en) | 2009-05-22 | 2009-05-22 | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101891665A true CN101891665A (en) | 2010-11-24 |
CN101891665B CN101891665B (en) | 2013-02-06 |
Family
ID=43101040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910051820 Expired - Fee Related CN101891665B (en) | 2009-05-22 | 2009-05-22 | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101891665B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665021A (en) * | 2013-12-03 | 2014-03-26 | 西安赛美科医药研发有限公司 | Synthetic method of biapenem drug intermediate 4-AA |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003277390A (en) * | 2002-03-25 | 2003-10-02 | Takasago Internatl Corp | Method for producing azetidinone compound |
CN101367831B (en) * | 2008-09-28 | 2011-12-07 | 重庆大学 | Midbody for preparing carbpenem antibiotics and method of preparing the same |
-
2009
- 2009-05-22 CN CN 200910051820 patent/CN101891665B/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665021A (en) * | 2013-12-03 | 2014-03-26 | 西安赛美科医药研发有限公司 | Synthetic method of biapenem drug intermediate 4-AA |
Also Published As
Publication number | Publication date |
---|---|
CN101891665B (en) | 2013-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111925381B (en) | A kind of synthetic method of baloxavir key intermediate | |
CN103113308A (en) | Method for preparing dihydropyrimidinone derivative | |
CN103910657A (en) | Ring opening method of aziridine compounds | |
CN105148988B (en) | A kind of chiral pyridoxal class catalyst and its synthetic method and application | |
CN105873904B (en) | The manufacture method of 2 amino-nicotinic acid benzyl derivatives | |
CN106188073A (en) | A kind of ecteinascidin 743 Alkaloid intermediate and its preparation method and application | |
CN101891665A (en) | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method | |
WO2021045879A1 (en) | Synthesis of deuterated aldehydes | |
CN103709101B (en) | Synthetic intermediate of one class renieramycin G and preparation method thereof | |
CN101121692A (en) | Synthetic method of α-carbonyl amides | |
CN103382162B (en) | Preparation method of acylazido compound | |
ES2312162T3 (en) | PROCEDURE FOR OBTAINING A SALT OF VALSARTAN USEFUL FOR THE PREPARATION OF VALSARTAN. | |
CN105801538B (en) | A kind of method for preparing 2,3- dihydro-benzofuran derivatives | |
CN109879832B (en) | A kind of 4-alkoxy-2-arylmercaptomorpholine-3,5-dione compound and preparation method thereof | |
KR101071440B1 (en) | USAGE OF POLY-3-HYDROXYBUTYRATES IN PREPARATION OF β-LACTAM COMPOUNDS | |
CN110590641B (en) | A kind of green preparation method of 3-hydroxyisoindol-1-one series compounds | |
JP4899385B2 (en) | Method for producing 3-aminomethyloxetane compound | |
CN118459375A (en) | A method for preparing N-sulfonyl amidine compound | |
JPWO2002076958A1 (en) | Method for producing 5-substituted oxazole compound and 5-substituted imidazole compound | |
CN101177416B (en) | (2'S,3'R,4S)-3-[2'-(N-substituted aminomethyl)-3'-hydroxy butyryl]-4-substituted oxazolidin-2-ketone derivative and preparation method thereof | |
CN104974101A (en) | Synthesis method of triazole-olefin compound | |
CN119735513A (en) | Synthesis method of unprotected 1, 2-amino ester and oxazoline derivative | |
CN105294517A (en) | Method for preparing chiral 1, 3-diamine | |
CN102153432B (en) | A kind of preparation method of α-trifluoromethyl-γ-carbonyl ester | |
CN102718695B (en) | Method for synthesizing aza-bicyclo octane [3.3.0] derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130206 Termination date: 20180522 |